Paget's disease of the breast natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Farima Kahe (talk | contribs) No edit summary |
||
| (28 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Paget's disease of the breast}} | {{Paget's disease of the breast}} | ||
{{CMG}};{{AE}} {{Preeti}} | |||
==Overview== | |||
The prognosis for people with Paget's disease of the breast is primarily determined by the underlying [[tumor]]. Unfavorable [[prognosis]] is seen in cases with palpable [[Breast cancer|breast tumor]], enlarged [[lymph nodes]]and in patients younger than 60 years of [[age]]. [[Prognosis]] is worse in males than in females. Mean [[Survival rate|survival]] was found to be 80.0 months for [[males]] and 108.2 months for [[females]]. Five-year [[Survival rates|survival rate]] has been reported to be 20-30% in [[males]], compared to 30-40% in [[females]]. This has been [[Hypothesis|hypothesized]] to be due to the small size of [[mammary]] gland in [[males]]. | |||
==Prognosis== | |||
*The prognosis for people with Paget's disease of the breast depends on a variety of factors, and is primarily determined by the underlying [[tumor]]. | |||
*Some factors indicate an unfavorable [[prognosis]], such as:<ref name="Lopes FilhoLopes2015">{{cite journal|last1=Lopes Filho|first1=Lauro Lourival|last2=Lopes|first2=Ione Maria Ribeiro Soares|last3=Lopes|first3=Lauro Rodolpho Soares|last4=Enokihara|first4=Milvia M. S. S.|last5=Michalany|first5=Alexandre Osores|last6=Matsunaga|first6=Nobuo|title=Mammary and extramammary Paget's disease|journal=Anais Brasileiros de Dermatologia|volume=90|issue=2|year=2015|pages=225–231|issn=1806-4841|doi=10.1590/abd1806-4841.20153189}}</ref><ref name="NIH">Paget's disease of the breast. National cancer institute. http://www.cancer.gov/types/breast/paget-breast-fact-sheet</ref> | |||
:*Presence of palpable [[breast tumor]] | |||
:*Enlarged [[lymph nodes]] | |||
:*Histological type of [[breast cancer]] | |||
:*Patients younger than 60 years | |||
*Prognosis of Paget's disease is worse in [[males]] than in [[females]]. | |||
===Survival rates=== | |||
*In patients with Paget's disease of the breast mean [[Survival rate|survival]] was found to be 80.0 months for [[males]] and 108.2 months for [[females]]. | |||
*Five-year [[Survival rates|survival rate]] has been reported to be 20-30% in [[males]], compared to 30-40% in [[females]]. This has been [[Hypothesis|hypothesized]] to be due to the small size of [[mammary gland]] in [[males]].<ref>{{cite journal|doi=10.1001/ archdermatol.2008.508.}}</ref><ref name="pmid25739183">{{cite journal |vauthors=Leibou L, Herman O, Frand J, Kramer E, Mordechai S |title=Paget's disease of the male breast with underlying ductal carcinoma in situ |journal=Isr. Med. Assoc. J. |volume=17 |issue=1 |pages=64–5 |date=January 2015 |pmid=25739183 |doi= |url=}}</ref> | |||
*The presence of invasive [[cancer]] in the affected [[breast]] and the spread of [[cancer]] to nearby [[Lymph node|lymph nodes]] are associated with reduced [[survival]]. | |||
*[[Lymph node]] involvement is correlated with median [[survival rates]], reaching 75-95% when negative and 20 to 25% when positive. | |||
*In another study, the mean 10-year [[survival rate]] was estimated at 47% in cases with positive [[lymph nodes]] and 93% in those with negative [[lymph nodes]]. | |||
*When the [[disease]] occurs in [[males]], the [[prognosis]] is poor, with an average 5-year [[Survival analysis|survival]] rate of 20-30%. | |||
*Patients with Paget disease concomitant infiltrating [[duct carcinoma]] (PD‐IDC)had the worst prognosis with 5‐year survival rate = 84.1%. | |||
*The Paget disease concomitant [[DICS|intraductal carcinoma]] (PD‐DCIS) had the best [[prognosis]] with 5‐year [[survival]] rate = 97.5%. | |||
*Among [[patients]] with Paget disease those who are married have a better [[prognosis]] than who were not. | |||
*Marital status is said to be associated with the [[hormone receptor]] status in patients with PD‐IDC.<ref name="pmid29722170">{{cite journal |vauthors=Zhao Y, Sun HF, Chen MT, Gao SP, Li LD, Jiang HL, Jin W |title=Clinicopathological characteristics and survival outcomes in Paget disease: a SEER population-based study |journal=Cancer Med |volume=7 |issue=6 |pages=2307–2318 |date=June 2018 |pmid=29722170 |pmc=6010794 |doi=10.1002/cam4.1475 |url=}}</ref><ref name="pmid30538501">{{cite journal |vauthors=Zhou H, Lu K, Zheng L, Guo L, Gao Y, Miao X, Chen Z, Wang X |title=Prognostic significance of mammary Paget's disease in Chinese women: a 10-year, population-based, matched cohort study |journal=Onco Targets Ther |volume=11 |issue= |pages=8319–8326 |date=2018 |pmid=30538501 |pmc=6260180 |doi=10.2147/OTT.S171710 |url=}}</ref> | |||
==References== | ==References== | ||
| Line 14: | Line 36: | ||
[[Category:Breast]] | [[Category:Breast]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Latest revision as of 18:15, 28 March 2019
|
Paget's disease of the breast Microchapters |
|
Differentiating Paget's disease of the breast from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Paget's disease of the breast natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Paget's disease of the breast natural history, complications and prognosis |
|
FDA on Paget's disease of the breast natural history, complications and prognosis |
|
CDC on Paget's disease of the breast natural history, complications and prognosis |
|
Paget's disease of the breast natural history, complications and prognosis in the news |
|
Blogs on Paget's disease of the breast natural history, complications and prognosis |
|
Directions to Hospitals Treating Paget's disease of the breast |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Overview
The prognosis for people with Paget's disease of the breast is primarily determined by the underlying tumor. Unfavorable prognosis is seen in cases with palpable breast tumor, enlarged lymph nodesand in patients younger than 60 years of age. Prognosis is worse in males than in females. Mean survival was found to be 80.0 months for males and 108.2 months for females. Five-year survival rate has been reported to be 20-30% in males, compared to 30-40% in females. This has been hypothesized to be due to the small size of mammary gland in males.
Prognosis
- The prognosis for people with Paget's disease of the breast depends on a variety of factors, and is primarily determined by the underlying tumor.
- Some factors indicate an unfavorable prognosis, such as:[1][2]
- Presence of palpable breast tumor
- Enlarged lymph nodes
- Histological type of breast cancer
- Patients younger than 60 years
Survival rates
- In patients with Paget's disease of the breast mean survival was found to be 80.0 months for males and 108.2 months for females.
- Five-year survival rate has been reported to be 20-30% in males, compared to 30-40% in females. This has been hypothesized to be due to the small size of mammary gland in males.[3][4]
- The presence of invasive cancer in the affected breast and the spread of cancer to nearby lymph nodes are associated with reduced survival.
- Lymph node involvement is correlated with median survival rates, reaching 75-95% when negative and 20 to 25% when positive.
- In another study, the mean 10-year survival rate was estimated at 47% in cases with positive lymph nodes and 93% in those with negative lymph nodes.
- When the disease occurs in males, the prognosis is poor, with an average 5-year survival rate of 20-30%.
- Patients with Paget disease concomitant infiltrating duct carcinoma (PD‐IDC)had the worst prognosis with 5‐year survival rate = 84.1%.
- The Paget disease concomitant intraductal carcinoma (PD‐DCIS) had the best prognosis with 5‐year survival rate = 97.5%.
- Among patients with Paget disease those who are married have a better prognosis than who were not.
- Marital status is said to be associated with the hormone receptor status in patients with PD‐IDC.[5][6]
References
- ↑ Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Paget's disease of the breast. National cancer institute. http://www.cancer.gov/types/breast/paget-breast-fact-sheet
- ↑ . doi:10.1001/ archdermatol.2008.508. Check
|doi=value (help). Missing or empty|title=(help) - ↑ Leibou L, Herman O, Frand J, Kramer E, Mordechai S (January 2015). "Paget's disease of the male breast with underlying ductal carcinoma in situ". Isr. Med. Assoc. J. 17 (1): 64–5. PMID 25739183.
- ↑ Zhao Y, Sun HF, Chen MT, Gao SP, Li LD, Jiang HL, Jin W (June 2018). "Clinicopathological characteristics and survival outcomes in Paget disease: a SEER population-based study". Cancer Med. 7 (6): 2307–2318. doi:10.1002/cam4.1475. PMC 6010794. PMID 29722170.
- ↑ Zhou H, Lu K, Zheng L, Guo L, Gao Y, Miao X, Chen Z, Wang X (2018). "Prognostic significance of mammary Paget's disease in Chinese women: a 10-year, population-based, matched cohort study". Onco Targets Ther. 11: 8319–8326. doi:10.2147/OTT.S171710. PMC 6260180. PMID 30538501.